Pharma & Biotech Growth Strategist
ABB
A complete application in a minute
Tailored resume and cover letter, ready to send.
Job summary
ABB is seeking a Strategic Segment Leader for Pharmaceutical & Biotechnology to drive growth within the life sciences market in the United States. The role focuses on early-stage opportunity identification, executive relationship development, market intelligence, and sales enablement across ABB’s Electrification, Motion, and Automation portfolios.
The incumbent will engage with pharmaceutical manufacturers, biotech firms, CDMOs, EPCs, engineering firms, OEMs, and integrators, traveling 40–60% as
Qualifications
- Bachelor's degree required; 10+ years of relevant experience.
- Minimum 5 years in business development or strategic sales.
- Experience in pharmaceutical, biotechnology, life sciences, or related markets.
- Knowledge of power distribution, automation, controls, or industrial infrastructure.
- Familiarity with regulated manufacturing environments (cGMP, validation, cleanroom).
Responsibilities
- Develop ABB's Pharmaceutical & Biotechnology growth strategy.
- Identify and qualify opportunities before RFQ issuance.
- Build executive relationships with pharmaceutical manufacturers, biotech firms, CDMOs, EPCs, engineering firms, OEMs, and integrators.
- Support thought leadership through industry events and associations.
- Monitor manufacturing, biologics, cell and gene therapy, and facility investment trends.
- Coordinate cross-business opportunities across Electrification, Motion, and Automation.
- Serve as Voice of the Market and provide sales enablement.
Skills
Education
Tools
Job description
ABB is seeking a Strategic Segment Leader for Pharmaceutical & Biotechnology to drive growth within the life sciences market in the United States. The role focuses on early-stage opportunity identification, executive relationship development, market intelligence, and sales enablement across ABB’s Electrification, Motion, and Automation portfolios.
The incumbent will engage with pharmaceutical manufacturers, biotech firms, CDMOs, EPCs, engineering firms, OEMs, and integrators, traveling 40–60% as
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
